サマリー

旅行用ワクチンの世界市場 2024-2028
旅行用ワクチン市場は2023〜2028年に39億7000万米ドル成長し、予測期間中のCAGRは8.64%で加速すると予測されます。当レポートでは、旅行用ワクチン市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、世界的な移民の増加、旅行者のワクチンで予防可能な病気に対する意識の高まり、ビザ発給前の予防接種に関する規制の義務化などが牽引しています。
Technavioの旅行用ワクチン市場は以下のように区分されています：
疾病タイプ別
- インフルエンザ
- ジフテリア
- 肝炎
- 腸チフス など
エンドユーザー別
- 成人用ワクチン
- 小児用ワクチン
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、世界的な旅行者の人口動態の変化が、今後数年間の旅行用ワクチン市場の成長を促進する主な要因のひとつであると分析しています。また、旅行に関連する疾病の発生率の増加や、旅行の安全性を確保するための政府やその他の組織による取り組みも、市場の大きな需要につながるでしょう。
本レポートでは、旅行用ワクチン市場について以下の分野をカバーしています：
- 旅行用ワクチン市場の規模
- 旅行用ワクチン市場予測
- 旅行用ワクチン市場の産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories、Altimmune Inc.、AstraZeneca Plc、Bavarian Nordic AS、Bharat Biotech Ltd.、CSL Ltd.、Dynavax Technologies Corp.、Emergent BioSolutions Inc.、GlaxoSmithKline Plc、KM Biologics Co.Ltd.、LG Chem Ltd.、Merck and Co.Ltd.、Novartis AG、Pfizer Inc.、Sanofi SA、Serum Institute of India Pvt.Ltd.、Shenzhen Kangtai Biological Products Co.Ltd.、SK Chemicals Co.Ltd.、Shenzhen Kangtai Biological Products Co.Ltd.、Shenzhen Kangtai Biological Products Co.また、旅行用ワクチン市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/travel-vaccines-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global travel vaccines market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global travel vaccines market 2018 - 2022 ($ billion)
o 4.2 Disease Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
o 4.3 End-user Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Disease Type
o 6.1 Market segments
o Exhibit 30: Chart on Disease Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Disease Type - Market share 2023-2028 (%)
o 6.2 Comparison by Disease Type
o Exhibit 32: Chart on Comparison by Disease Type
o Exhibit 33: Data Table on Comparison by Disease Type
o 6.3 Influenza - Market size and forecast 2023-2028
o Exhibit 34: Chart on Influenza - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Influenza - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Influenza - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Influenza - Year-over-year growth 2023-2028 (%)
o 6.4 Diptheria - Market size and forecast 2023-2028
o Exhibit 38: Chart on Diptheria - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Diptheria - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Diptheria - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Diptheria - Year-over-year growth 2023-2028 (%)
o 6.5 Hepatitis - Market size and forecast 2023-2028
o Exhibit 42: Chart on Hepatitis - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Hepatitis - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Hepatitis - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Hepatitis - Year-over-year growth 2023-2028 (%)
o 6.6 Typhoid and others - Market size and forecast 2023-2028
o Exhibit 46: Chart on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on Typhoid and others - Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Typhoid and others - Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Disease Type
o Exhibit 50: Market opportunity by Disease Type ($ billion)
o Exhibit 51: Data Table on Market opportunity by Disease Type ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 54: Chart on Comparison by End-user
o Exhibit 55: Data Table on Comparison by End-user
o 7.3 Adult vaccines - Market size and forecast 2023-2028
o Exhibit 56: Chart on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Adult vaccines - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Adult vaccines - Year-over-year growth 2023-2028 (%)
o 7.4 Pediatric vaccines - Market size and forecast 2023-2028
o Exhibit 60: Chart on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by End-user
o Exhibit 64: Market opportunity by End-user ($ billion)
o Exhibit 65: Data Table on Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.10 Japan - Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.11 China - Market size and forecast 2023-2028
o Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 115: Abbott Laboratories - Overview
o Exhibit 116: Abbott Laboratories - Business segments
o Exhibit 117: Abbott Laboratories - Key news
o Exhibit 118: Abbott Laboratories - Key offerings
o Exhibit 119: Abbott Laboratories - Segment focus
o 12.4 AstraZeneca Plc
o Exhibit 120: AstraZeneca Plc - Overview
o Exhibit 121: AstraZeneca Plc - Product / Service
o Exhibit 122: AstraZeneca Plc - Key news
o Exhibit 123: AstraZeneca Plc - Key offerings
o 12.5 Bharat Biotech Ltd.
o Exhibit 124: Bharat Biotech Ltd. - Overview
o Exhibit 125: Bharat Biotech Ltd. - Product / Service
o Exhibit 126: Bharat Biotech Ltd. - Key news
o Exhibit 127: Bharat Biotech Ltd. - Key offerings
o 12.6 CSL Ltd.
o Exhibit 128: CSL Ltd. - Overview
o Exhibit 129: CSL Ltd. - Business segments
o Exhibit 130: CSL Ltd. - Key offerings
o Exhibit 131: CSL Ltd. - Segment focus
o 12.7 Dynavax Technologies Corp.
o Exhibit 132: Dynavax Technologies Corp. - Overview
o Exhibit 133: Dynavax Technologies Corp. - Product / Service
o Exhibit 134: Dynavax Technologies Corp. - Key offerings
o 12.8 GlaxoSmithKline Plc
o Exhibit 135: GlaxoSmithKline Plc - Overview
o Exhibit 136: GlaxoSmithKline Plc - Business segments
o Exhibit 137: GlaxoSmithKline Plc - Key news
o Exhibit 138: GlaxoSmithKline Plc - Key offerings
o Exhibit 139: GlaxoSmithKline Plc - Segment focus
o 12.9 KM Biologics Co. Ltd.
o Exhibit 140: KM Biologics Co. Ltd. - Overview
o Exhibit 141: KM Biologics Co. Ltd. - Product / Service
o Exhibit 142: KM Biologics Co. Ltd. - Key offerings
o 12.10 LG Chem Ltd.
o Exhibit 143: LG Chem Ltd. - Overview
o Exhibit 144: LG Chem Ltd. - Business segments
o Exhibit 145: LG Chem Ltd. - Key news
o Exhibit 146: LG Chem Ltd. - Key offerings
o Exhibit 147: LG Chem Ltd. - Segment focus
o 12.11 Merck and Co. Inc.
o Exhibit 148: Merck and Co. Inc. - Overview
o Exhibit 149: Merck and Co. Inc. - Business segments
o Exhibit 150: Merck and Co. Inc. - Key news
o Exhibit 151: Merck and Co. Inc. - Key offerings
o Exhibit 152: Merck and Co. Inc. - Segment focus
o 12.12 Novartis AG
o Exhibit 153: Novartis AG - Overview
o Exhibit 154: Novartis AG - Business segments
o Exhibit 155: Novartis AG - Key offerings
o Exhibit 156: Novartis AG - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 157: Pfizer Inc. - Overview
o Exhibit 158: Pfizer Inc. - Product / Service
o Exhibit 159: Pfizer Inc. - Key news
o Exhibit 160: Pfizer Inc. - Key offerings
o 12.14 Sanofi SA
o Exhibit 161: Sanofi SA - Overview
o Exhibit 162: Sanofi SA - Business segments
o Exhibit 163: Sanofi SA - Key news
o Exhibit 164: Sanofi SA - Key offerings
o Exhibit 165: Sanofi SA - Segment focus
o 12.15 Serum Institute of India Pvt. Ltd.
o Exhibit 166: Serum Institute of India Pvt. Ltd. - Overview
o Exhibit 167: Serum Institute of India Pvt. Ltd. - Product / Service
o Exhibit 168: Serum Institute of India Pvt. Ltd. - Key offerings
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 Valneva SE
o Exhibit 173: Valneva SE - Overview
o Exhibit 174: Valneva SE - Business segments
o Exhibit 175: Valneva SE - Key offerings
o Exhibit 176: Valneva SE - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global travel vaccines market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Disease Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Disease Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Disease Type
Exhibits33: Data Table on Comparison by Disease Type
Exhibits34: Chart on Influenza - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Influenza - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Influenza - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Influenza - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Diptheria - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Diptheria - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Diptheria - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Diptheria - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Hepatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Hepatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Hepatitis - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Hepatitis - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Typhoid and others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Typhoid and others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Disease Type ($ billion)
Exhibits51: Data Table on Market opportunity by Disease Type ($ billion)
Exhibits52: Chart on End-user - Market share 2023-2028 (%)
Exhibits53: Data Table on End-user - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Adult vaccines - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Adult vaccines - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by End-user ($ billion)
Exhibits65: Data Table on Market opportunity by End-user ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: AstraZeneca Plc - Overview
Exhibits121: AstraZeneca Plc - Product / Service
Exhibits122: AstraZeneca Plc - Key news
Exhibits123: AstraZeneca Plc - Key offerings
Exhibits124: Bharat Biotech Ltd. - Overview
Exhibits125: Bharat Biotech Ltd. - Product / Service
Exhibits126: Bharat Biotech Ltd. - Key news
Exhibits127: Bharat Biotech Ltd. - Key offerings
Exhibits128: CSL Ltd. - Overview
Exhibits129: CSL Ltd. - Business segments
Exhibits130: CSL Ltd. - Key offerings
Exhibits131: CSL Ltd. - Segment focus
Exhibits132: Dynavax Technologies Corp. - Overview
Exhibits133: Dynavax Technologies Corp. - Product / Service
Exhibits134: Dynavax Technologies Corp. - Key offerings
Exhibits135: GlaxoSmithKline Plc - Overview
Exhibits136: GlaxoSmithKline Plc - Business segments
Exhibits137: GlaxoSmithKline Plc - Key news
Exhibits138: GlaxoSmithKline Plc - Key offerings
Exhibits139: GlaxoSmithKline Plc - Segment focus
Exhibits140: KM Biologics Co. Ltd. - Overview
Exhibits141: KM Biologics Co. Ltd. - Product / Service
Exhibits142: KM Biologics Co. Ltd. - Key offerings
Exhibits143: LG Chem Ltd. - Overview
Exhibits144: LG Chem Ltd. - Business segments
Exhibits145: LG Chem Ltd. - Key news
Exhibits146: LG Chem Ltd. - Key offerings
Exhibits147: LG Chem Ltd. - Segment focus
Exhibits148: Merck and Co. Inc. - Overview
Exhibits149: Merck and Co. Inc. - Business segments
Exhibits150: Merck and Co. Inc. - Key news
Exhibits151: Merck and Co. Inc. - Key offerings
Exhibits152: Merck and Co. Inc. - Segment focus
Exhibits153: Novartis AG - Overview
Exhibits154: Novartis AG - Business segments
Exhibits155: Novartis AG - Key offerings
Exhibits156: Novartis AG - Segment focus
Exhibits157: Pfizer Inc. - Overview
Exhibits158: Pfizer Inc. - Product / Service
Exhibits159: Pfizer Inc. - Key news
Exhibits160: Pfizer Inc. - Key offerings
Exhibits161: Sanofi SA - Overview
Exhibits162: Sanofi SA - Business segments
Exhibits163: Sanofi SA - Key news
Exhibits164: Sanofi SA - Key offerings
Exhibits165: Sanofi SA - Segment focus
Exhibits166: Serum Institute of India Pvt. Ltd. - Overview
Exhibits167: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits168: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits169: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits170: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits171: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits173: Valneva SE - Overview
Exhibits174: Valneva SE - Business segments
Exhibits175: Valneva SE - Key offerings
Exhibits176: Valneva SE - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations